759 Effectiveness of bevacizumab in platinum-resistant recurrent epithelial ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

759 Effectiveness of bevacizumab in platinum-resistant recurrent epithelial ovarian cancer

Free

Online download statistics by month:

Online download statistics by month: October 2021 to March 2023

	Abstract	Full	Pdf
Oct 2021	60	0	11
Nov 2021	56	0	13
Dec 2021	19	0	2
Jan 2022	44	0	3
Feb 2022	17	0	0
Mar 2022	19	0	5
Apr 2022	32	0	6
May 2022	21	0	5
Jun 2022	37	0	4
Jul 2022	16	0	2
Aug 2022	46	0	10
Sep 2022	16	0	8
Oct 2022	22	0	2
Nov 2022	31	0	4
Dec 2022	48	0	3
Jan 2023	19	0	5
Feb 2023	28	0	0
Mar 2023	12	0	0
Total	543	0	83